Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort

References

• Herrinton LJ, Liu L, Lafata JE, Allison JE, Andrade SE, Korner EJ, Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007;13:451–61.
   PubMed Web of Science ®Google Scholar
• Loftus CG, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ III, Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis 2007;13:254–61.
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's-disease in the County of Copenhagen, 1962–87 – a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609–14.
   PubMed Web of Science ®Google Scholar
• Lapidus A. Crohn's disease in Stockholm County during 1990–2001: an epidemiological update. World J Gastroenterol 2006;12:75–81.
   PubMed Web of Science ®Google Scholar
• Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553–9.
   PubMed Web of Science ®Google Scholar
• Juillerat P, Pittet V, Bulliard JL, Guessous I, Antonino AT, Mottet C, Prevalence of inflammatory bowel disease in the Canton of Vaud (Switzerland): a population-based cohort study. J Crohn's Colitis 2008;2:131–41.
   Google Scholar
• Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690–7.
   PubMed Web of Science ®Google Scholar
• Stockbrügger RW, Russel MGVM, van Blankenstein M, Shivananda S. EC-IBD: a European effort in inflammatory bowel disease. Eur J Intern Med 2000;11:187–90.
   PubMedGoogle Scholar
• D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008;371:660–7.
   PubMed Web of Science ®Google Scholar
• Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895–902.
   PubMed Web of Science ®Google Scholar
• Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010;138:463–8.
   Google Scholar
• Lennard-Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol 1997;9:353–9.
   PubMedGoogle Scholar
• Witte J, Shivananda S, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi C, Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 2000;35:1272–7.
   PubMed Web of Science ®Google Scholar
• Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut 2006;55:1124–30.
   PubMed Web of Science ®Google Scholar
• Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006;131:719–28.
   PubMed Web of Science ®Google Scholar
• Vader JP, Froehlich F, Juillerat P, Burnand B, Felley C, Gonvers JJ, Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach – EPACT. Digestion 2006;73:237–48.
   PubMedGoogle Scholar
• Dubois RW. On the second European Panel on the Appropriateness of Crohn's disease Therapy (EPACT II). J Crohn's Colitis 2009;3:223–4.
   Google Scholar
• Felley C, Vader J-P, Juillerat P, Pittet V, O'Morain C, Panis Y, Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: results of a multidisciplinary expert panel – EPACT II. J Crohn's Colitis 2009;3:250–6.
   Google Scholar
• Juillerat P, Vader J-P, Felley C, Pittet V, Gonvers J-J, Mottet C, Appropriate maintenance treatment for Crohn's disease: results of a multidisciplinary international expert panel – EPACT II. J Crohn's Colitis 2009;3:241–9.
   Google Scholar
• Michetti P, Stelle M, Juillerat P, Gassull M, Heil FJ, Stange E, Appropriateness of therapy for active Crohn's disease: results of a multidisciplinary international expert panel – EPACT II. J Crohn's Colitis 2009;3:232–40.
   Google Scholar
• Mottet C, Vader J-P, Felley C, Froehlich F, Gonvers J-J, Juillerat P, Appropriate management of special situations in Crohn's disease (upper gastro-intestinal: extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): results of a multidisciplinary international expert panel – EPACT II. J Crohn's Colitis 2009;3:257–63.
   Google Scholar
• Wolters FL, van Zeijl G, Sijbrandij J, Wessels F, O'Morain C, Limonard C, Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates. World J Gastroenterol 2005;11:7152–8.
   PubMedGoogle Scholar
• Hanauer SB, Sandborn W. Management of Crohn's disease in adults. Am J Gastroenterol 2001;96:635–43.
   PubMed Web of Science ®Google Scholar
• Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 2005;100:1357–61.
   PubMed Web of Science ®Google Scholar
• Kornbluth A, Hayes M, Feldman S, Hunt M, Fried-Boxt E, Lichtiger S, Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am J Gastroenterol 2006;101:1546–50.
   PubMedGoogle Scholar
• Herrinton LJ, Liu L, Fireman B, Lewis J, Allison J, Flowers N, Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998–2005. Gastroenterology 2009;137:502–11.
   PubMed Web of Science ®Google Scholar
• Marehbian J, Arrighi HM, Hass S, Tian H, Sandborn WJ. Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. Am J Gastroenterol 2009;104:2524–33.
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Meyers S. Management of Crohn's disease in adults. Am J Gastroenterol 1997;92:559–66.
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Am J Gastroenterol 2009;104:465–83.
   PubMed Web of Science ®Google Scholar
• Seow CH, Benchimol EI, Griffiths AM, Otley AR, Hillary SA. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008:CD000296.
   Google Scholar
• Hanauer SB, Stromberg U. Oral Pentasa in the treatment of active Crohn's disease: a meta-analysis of double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol 2004;2:379–88.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ. Evidence-based treatment algorithm for mild to moderate Crohn's disease. Am J Gastroenterol 2003;98:S1–5.
   PubMedGoogle Scholar
• Bar-Meir S. Mild to moderate Crohn's disease: still room for step-up therapies? Dig Dis 2009;27:347–50.
   PubMedGoogle Scholar
• Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383–95.
   PubMed Web of Science ®Google Scholar
• Dignass A, Assche GV, Lindsay JO, Lémann M, Söderholm J, Colombel JF, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohn's Colitis 2010;4:28–62.
   Google Scholar
• Lakatos PL. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J Gastroenterol 2009;15:4234–9.
   PubMed Web of Science ®Google Scholar
• Pittet V, Juillerat P, Mottet C, Felley C, Ballabeni P, Burnand B, Cohort Profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol 2009;38:922–31.
   PubMed Web of Science ®Google Scholar